References
Adegbola (2012). Childhood pneumonia as a global health priority and the strategic interest of the Bill & Melinda Gates Foundation. Clinical infectious diseases, 54(suppl_2), S89-S92.
Allaw et al (2021). First Candida auris Outbreak during a COVID-19 Pandemic in a Tertiary-Care Center in Lebanon. Pathogens, 10(2), 157.
Basso et al (2021). COVID-19-associated histoplasmosis in an AIDS patient. Mycopathologia, 186(1), 109-112.
Brissot et al (2021). Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation, 56(3), 532-535.
Chen et al (2021). Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate. Biochimica et Biophysica Acta (BBA)-General Subjects, 1865(6), 129893.
Chi et al (2020). Beyond COVID-19: A Whole of Health Look at Impacts During the Pandemic Response.
Chohan (2020). After the Coronavirus Vaccine’s Discovery: Concerns Regarding a COVID-19 Vaccination’s Distribution.
Chohan (2020). Economics in a Pandemic: Observations from the First Six Months of Coronavirus.
Das, R. C. Management of COVID-19 Through Strategic Roles of Governments: A Study on Highly Affected Countries. Management Strategies to Survive in a Competitive Environment: How to Improve Company Performance, 275.
Das, R. C. Management of COVID-19 Through Strategic Roles of Governments: A Study on Highly Affected Countries. Management Strategies to Survive in a Competitive Environment: How to Improve Company Performance, 275.
Erku et al (2021). When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the'infodemic'surrounding COVID-19. Research in Social and Administrative Pharmacy, 17(1), 1954-1963.
Excler et al (2021). Vaccine development for emerging infectious diseases. Nature medicine, 1-10.
Garg et al (2021). Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia, 1-10.
Gholipour et al (2021). COVID-19 infection risk from exposure to aerosols of wastewater treatment plants. Chemosphere, 273, 129701.
Hassard et al (2021). Innovation in wastewater near-source tracking for rapid identification of COVID-19 in schools. The Lancet Microbe, 2(1), e4-e5.
https://www.bbc.com/future/article/20210519-mucormycosis-the-black-fungus-hitting-indias-covid-patients
Jamka et al (2019). Accelerating typhoid conjugate vaccine introduction: what can be learned from prior new vaccine introduction initiatives?. Clinical Infectious Diseases, 68(Supplement_2), S171-S176.
John et al (2021). When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. Journal of Fungi, 7(4), 298.
Kanwar et al (2021). A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19. Journal of Fungi, 7(3), 174.
Khurana et al (2021). Profile of coinfections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance. Indian journal of medical microbiology, 39(2), 147-153.
Kumar et al (2021). SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India. Clinical Microbiology and Infection, 27(3), 481-483.
Marimuthu et al (2021). HIV and SARS CoV-2 coinfection: A retrospective, record-based, case series from South India. Journal of medical virology, 93(1), 163-165.
Mohindra et al (2021). COVID-19 infection in a HIV positive health care worker: first case report from a tertiary care hospital of North India. VirusDisease, 1-5.
Moorthy et al (2021). SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids—An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis. Journal of Maxillofacial and Oral Surgery, 1-8.
Mussini et al (2021). Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT). Clinical Microbiology and Infection, 27(3), 389-395.
Noushad and Al-Saqqaf (2021). COVID-19 case fatality rates can be highly misleading in resource-poor and fragile nations: the case of Yemen. Clinical Microbiology and Infection, 27(4), 509-510.
Pilato et al (2021). Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic. Journal of Fungi, 7(2), 140.
Prestel et al (2021). Candida auris outbreak in a COVID-19 specialty care unit—Florida, July–August 2020. Morbidity and Mortality Weekly Report, 70(2), 56.
Salmanton-García et al (2021). COVID-19–associated pulmonary aspergillosis, March–August 2020. Emerging infectious diseases, 27(4), 1077.
Sen et al (2021). Mucor in a viral land: A tale of two pathogens. Indian journal of ophthalmology, 69(2), 244.
Sim et al(2021). Costs of immunization programs for 10 vaccines in 94 low-and middle-income countries from 2011 to 2030. Value in Health, 24(1), 70-77.
Soin et al (2021). Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Respiratory Medicine, 9(5), 511-521.
Thompson and Kalkowska (2021). Potential future use, costs, and value of poliovirus vaccines. Risk Analysis, 41(2), 349-363.
Toh et al (2021). Human papillomavirus vaccination after COVID-19. JNCI Cancer Spectrum, 5(2), pkab011.
Torner (2020). Collateral effects of Covid-19 pandemic emergency response on worldwide immunizations. Vacunas (English Edition), 21(2), 73.
Wang et al (2021). Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19. Journal of thrombosis and thrombolysis, 51(3), 657-662.
